Description
| Details | Information |
| Brand Name | Enfiera 500 mg Injection |
| Active Ingredient | Rituximab |
| Drug Class | Anti-CD20 Monoclonal Antibody |
| Dosage Form | Injection |
| Route | Intravenous (IV) Infusion |
| Common Uses | NHL, CLL, Rheumatoid Arthritis, GPA and MPA |
| Manufacturer | Zydus Lifesciences Ltd. |
Enfiera 500 Injection is a rituximab-based medicine that helps manage certain cancers and autoimmune diseases. It may be used for conditions such as non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis. Rituximab may also be prescribed for other specific conditions depending on the doctor’s advice and treatment guidelines.
Enfiera 500mg Injection is given through an intravenous (IV) infusion by a doctor or trained healthcare professional. The required dose and treatment schedule depend on the condition being treated and the patient’s health. During treatment, doctors may monitor for infusion reactions, infections, and changes in blood-cell counts.
What Is Enfiera 500 mg Injection?
Enfiera 500 mg Injection is a prescription medicine used to treat certain cancers and autoimmune conditions. It contains rituximab 500 mg, which belongs to a group of medicines known as anti-CD20 monoclonal antibodies. Rituximab works by targeting specific B cells that can contribute to certain blood cancers and immune-related diseases.
Enfiera 500 Injection is commonly used for conditions such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis.
Enfiera Injection 500 mg is administered through an intravenous (IV) infusion. A doctor or trained nurse administers this medicine, and patients are monitored during treatment because infusion-related reactions can occur. The dose and treatment schedule are decided by the doctor based on the condition and individual medical needs.
How Does Enfiera 500 mg Injection Work?
Rituximab in Enfiera 500 mg Injection helps control certain diseases by targeting specific B cells in the body. It attaches to a protein called CD20, which is found on the surface of certain B lymphocytes. After attaching to CD20, rituximab helps the immune system destroy these targeted B cells.
B cells can be involved in the development of some blood cancers and can also contribute to abnormal immune activity in conditions such as rheumatoid arthritis. By reducing these B cells, Enfiera 500 mg Injection can help manage disease activity when prescribed for suitable conditions.
Because rituximab affects B cells and the immune system, doctors may monitor patients for infections, changes in blood-cell levels, and other treatment-related effects during therapy.
Uses of Enfiera 500 mg Injection
Enfiera 500 mg injection uses include treatment of several conditions where B-cell activity has an important role. Depending on the prescribed indication, it may be used for:
- Non-Hodgkin lymphoma (NHL)
- Chronic lymphocytic leukemia (CLL)
- Rheumatoid arthritis
- Granulomatosis with polyangiitis (GPA)
- Microscopic polyangiitis (MPA)
Dosage of Enfiera 500 mg Injection
The dose of Enfiera 500 Injection depends on the condition being treated and is different for each patient. A doctor decides the right dose and treatment schedule based on the disease, previous treatment, overall health, and response to medicine. Rituximab may be given in different dosing schedules depending on the medical condition.
Patients should not decide their dose or change infusion timings on their own. Before and during treatment, doctors may perform blood tests and other medical checks. Regular monitoring helps healthcare professionals check the patient’s response and identify possible side effects or complications early.
Substitutes and Alternatives for Enfiera 500 mg Injection
- Rituxirel 100 Injection
- Rituxirel 500 Injection
- Mabtas 500 Injection
- Mabtas 100 Infusion
- Maball 500 Injection
- Maball 100 Injection
How Is Enfiera 500 mg Injection Given?
Enfiera 500 mg injection is given through a vein as an intravenous (IV) infusion by a doctor or trained healthcare professional. It should not be injected or used by yourself.
Before starting treatment, your healthcare team may give medicines such as an antihistamine, pain reliever, or corticosteroid to help reduce infusion-related reactions. During the infusion, you may be closely monitored for symptoms such as fever, chills, rash, breathing problems, or changes in blood pressure.
Your doctor may also continue monitoring you for some time after treatment. The infusion time and treatment schedule can vary depending on your condition and prescribed treatment plan.
Side Effects of Enfiera 500 mg Injection
Common side effects
Enfiera 500 mg Injection may cause some side effects during or after treatment. Common side effects may include:
- Headache
- Weakness
- Fever
- Chills
- Infection
- Abdominal pain
- Back pain
- Low white blood cell count
- Lymphopenia
- Infusion-related reactions
Serious Side Effects
Serious side effects are uncommon but can require immediate medical attention. Rituximab prescribing information highlights the following important risks:
- Severe infusion-related reactions
- Serious infections
- Hepatitis B reactivation
- Severe skin or mucous membrane reactions
- Progressive multifocal leukoencephalopathy (PML)
- Severe breathing difficulty
- Chest pain or changes in heartbeat
- Severe allergic reactions or swelling
Precautions and Warnings
Before receiving Enfiera Injection 500 mg, tell your doctor about your complete medical history and all medicines you use.
Important precautions include:
- Infections: Rituximab can increase the risk of infections. Report fever, persistent cough, sore throat, or other signs of infection.
- Hepatitis B: Screening and monitoring may be required because rituximab can reactivate hepatitis B infection.
- Heart conditions: Patients with certain heart problems may require closer monitoring.
- Kidney problems: Kidney function may need monitoring in appropriate clinical situations.
- Vaccination: Tell your doctor about planned or recent vaccinations.
- Pregnancy: Rituximab can cause fetal harm, so pregnancy status and contraception should be discussed with the treating doctor.
- Surgery: Inform your healthcare team if you are planning surgery.
Drug Interactions of Enfiera 500 mg Injection
Enfiera 500 mg Injection may interact with certain medicines and treatments that affect the immune system. Tell your doctor about all medicines, supplements, or herbal products you are taking before starting treatment.
Vaccines also need special attention during rituximab treatment. Live vaccines are generally not recommended during treatment, while other vaccines may need to be given at a specific time. Your doctor can advise you about which vaccines are suitable and when they should be taken.
Enfiera 500 mg Injection Storage
Enfiera 500 mg Injection should be stored in a refrigerator at 2°C to 8°C and should not be frozen. Proper cold-chain handling is important for maintaining product quality. Because this is an injectable prescription medicine, storage and handling should generally be managed by the pharmacy or healthcare facility according to product requirements.
Buy Enfiera 500 mg Injection Online
You can conveniently buy Enfiera 500 mg Injection online from EasyRxDose with a valid prescription. Before placing your order, make sure you have a prescription from a licensed healthcare professional. Choose a trusted pharmacy to help ensure you receive genuine medicine. Enfiera 500 mg Injection contains rituximab and should be purchased from a reliable source.
